Small Cell Lung Cancer (SCLC) Consortium: Biology, Therapy and Resistance (U01)

קרןNational Cancer Institute/NIH
מדינהU.S.A.
סוגResearch Grants
תאריך אחרון11/03/2020
תאריכים נוספים12/11/2020
11/03/2021
12/11/2021
11/03/2022
פקולטהLife Sciences, Medicine
תיאור

This grant invites applications for research projects to join the Small-Cell Lung Cancer (SCLC) Consortium.

Goals of the SCLC Consortium pertinent to this FOA are:

1) to learn the mechanistic and biological underpinnings of SCLC formation, progression and heterogeneity;

2) to investigate how molecular vulnerabilities could be used to develop targeted agents or combinations;

3) to understand clinical resistance to drug and radiation therapy and its rapid development

 

 

Funding: $450,000 per year 

Duration: 5 years

 

Research Authority due date: 10 days prior to submission

LOI (encouraged) due dates: 12.10.19, 11.2.20, 12.10.20, 11.2.21, 12.10.21, 11.2.22

Full proposal due dates:  12.11.19, 11.3.20, 12.11.20, 11.3.21, 12.11.21, 11.3.22

קבצים מצורפים
קישורלאתר
עדכון אחרוןעדכון אחרון: 02/09/2019
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive